Post-approval studies (Phase 4)Study completedNCT05125029What this trial is testingBotulinum Toxin in Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon Emory University 24
Not applicableEnded earlyNCT03869008What this trial is testingPotential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.Who this might be right forRaynaud PhenomenonPrimary Raynaud PhenomenonRaynaud Disease+1 more University of Toledo Health Science Campus 6
Large-scale testing (Phase 3)Study completedNCT01280266What this trial is testingEfficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud PhenomenonWho this might be right forRaynaud Phenomenon Seoul National University Hospital 29
Not applicableStudy completedNCT00946738What this trial is testingThe Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's PhenomenonSystemic Sclerosis Charite University, Berlin, Germany 28
Testing effectiveness (Phase 2)UnknownNCT02356809What this trial is testingSafety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's PhenomenonWho this might be right forSecondary Raynaud's Phenomenon Artgen Biotech 30
Large-scale testing (Phase 3)UnknownNCT00934427What this trial is testingStudy of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon SymptomsWho this might be right forRaynaud Disease MediQuest Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT00378521What this trial is testingDose Response Study of a Topical Gel for the Treatment of Raynaud's PhenomenonWho this might be right forRaynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Autoimmune Disease MediQuest Therapeutics 15
Not applicableStudy completedNCT05094687What this trial is testingCutaneous Manifestations of Coronavirus Disease 2019(COVID-19).Who this might be right forCutaneous ManifestationsSkin ManifestationsCOVID-19+5 more Jinnah Postgraduate Medical Centre 1,206
Post-approval studies (Phase 4)Study completedNCT00048763What this trial is testingSafety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Disease Otsuka America Pharmaceutical 75
Not applicableWithdrawnNCT03393325What this trial is testingTadalafil-Delivra and Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Large-scale testing (Phase 3)Study completedNCT00498615What this trial is testingA Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's PhenomenonWho this might be right forRaynaudScleroderma Johns Hopkins University 17
Not applicableStudy completedNCT02506062What this trial is testingA Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)Who this might be right forRaynaud DiseaseRaynaud's Phenomenon London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 21
Large-scale testing (Phase 3)Study completedNCT00626665What this trial is testingRandomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in SclerodermaWho this might be right forRaynaud Disease Sanjay Gandhi Postgraduate Institute of Medical Sciences 25
Very early researchWithdrawnNCT04656704What this trial is testingHyaluronidase in Treating Oral Microstomia in Patients With Sclerosing Skin DiseaseWho this might be right forMicrostomiaSclerodermaCREST Syndrome+2 more Brigham and Women's Hospital
Large-scale testing (Phase 3)Study completedNCT01347008What this trial is testingEffect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic SclerosisWho this might be right forScleroderma, SystemicScleroderma, DiffuseScleroderma, Limited+1 more Federal University of São Paulo 41
Testing effectiveness (Phase 2)Study completedNCT01309802What this trial is testingA Two-Part Study of BOTOX® Therapy for Ischemic DigitsWho this might be right forRaynaud's Disease Southern Illinois University 48
Not applicableUnknownNCT04650659What this trial is testingFunctional Exercise Tests in Patients With Systemic SclerosisWho this might be right forScleroderma, SystemicLung Diseases, InterstitialPulmonary Arterial Hypertension+1 more University of Aarhus 83
Large-scale testing (Phase 3)Study completedNCT00253331What this trial is testingLab Study of MQX-503 in Treatment of Raynaud'sWho this might be right forRaynaud DiseaseRaynaud Disease Secondary to SclerodermaRaynaud Secondary to Other Autoimmune Disease MediQuest Therapeutics 36
Not applicableUnknownNCT03984422What this trial is testingApplication for Monitoring and Evaluation of Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon University Hospital, Grenoble 120
Not applicableStudy completedNCT04644523What this trial is testingDermoscopy in Primary Raynaud's PhenomenonWho this might be right forRaynaud Phenomenon Assistance Publique - Hôpitaux de Paris 100